title: Alterations in the properties and isoform ratios of brain Na+/K(+)-ATPase in streptozotocin diabetic rats.
abstract: In this study we analysed the changes in the properties of rat cerebral cortex Na+K(+)-ATPase in streptozotocin induced diabetes (STZ-diabetes). Special attempt was made to determine whether insulin treatment of diabetic animals could restore the altered parameters of this enzyme. Na+/K(+)-ATPase activity was found to be decreased by 15% after 2 weeks, and by 37% after 4 weeks in diabetic rat brains with a parallel decrease in maximal capacity of low affinity ouabain binding sites. There was no significant change in the high affinity ouabain binding sites. The Kd values did not change significantly. Western blot analysis of brain Na+/K(+)-ATPase isoforms indicated a 61 +/- 5.8% and 20 +/- 2.8% decrease of the alpha 1 and alpha 3 isoforms, respectively in 4 weeks diabetic animals. Change in the amount of the alpha 2 isoform proved to be less characteristic. Both types of beta subunit isoform showed a significant decrease in four weeks diabetic rats. Our data indicate a good correlation in diabetic rats between changes in Na-/K(+)-ATPase activity, low affinity ouabain binding capacity and the level of alpha 1 isoform. While insulin treatment of diabetic animals restored the blood glucose level to normal, a complete reversal of diabetes induced changes in Na+/K(+)-ATPase activity, ouabain binding capacity and Na+/K(+)-ATPase isoform composition could not be achieved.
authors.affiliation: Semmelweis University School of Medicine, Department of Biochemistry I, Budapest, Hungary.
authors.forename: A
authors.initials: A
authors.lastname: Vér
authors.forename: P
authors.initials: P
authors.lastname: Csermely
authors.forename: T
authors.initials: T
authors.lastname: Bányász
authors.forename: T
authors.initials: T
authors.lastname: Kovács
authors.forename: J
authors.initials: J
authors.lastname: Somogyi
mesh_terms: D000818:Animals; D001665:Binding Sites; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D002540:Cerebral Cortex / Q000201:enzymology*; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy / Q000201:enzymology*; D007328:Insulin / Q000627:therapeutic use; D007527:Isoenzymes / Q000378:metabolism*; D008297:Male; D008861:Microsomes / Q000201:enzymology; D010042:Ouabain / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D013311:Streptozocin; D014316:Tritium
chemical_list: D001786:Blood Glucose; D007328:Insulin; D007527:Isoenzymes; D014316:Tritium; D010042:Ouabain; D013311:Streptozocin; D000254:Sodium-Potassium-Exchanging ATPase